Back to Pediatrics
Pediatricsv1999Evidence-Based

Hour-Specific Risk for Neonatal Hyperbilirubinemia

Predicts risk of hyperbilirubinemia in neonates based on total serum bilirubin measurement using the Bhutani nomogram. Identifies infants at risk for subsequent significant hyperbilirubinemia.

Clinical Input Parameters

hours
Range: 12 — 168 hours
mg/dL
Range: 0.1 — 30 mg/dL
Clinical Assessment
Awaiting Parameters
risk zone
—zone
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Hour-Specific Risk for Neonatal Hyperbilirubinemia is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Risk zone based on hour-specific bilirubin percentiles from Bhutani nomogram

Clinical Pearls & Practice Notes

  • Only for neonates ≥35 weeks gestational age
  • Not for neonates with positive direct Coombs test
  • Not for neonates who received phototherapy before 60 hours of age
  • Not for determining need for exchange transfusion
  • Risk refers to the risk of a subsequent bilirubin level >95th percentile
  • Recommended follow-up timing: Discharged <24 hrs see by 72 hrs, 24-48 hrs see by 96 hrs, 48-72 hrs see by 120 hrs
  • Consider clinical risk factors including: exclusive breastfeeding, East Asian race, cephalhematoma, significant bruising, sibling with jaundice
  • Based on data from 2,840 healthy term and near-term newborns

Evidence & Literature Citations

  1. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999 Jan;103(1):6-14.
  2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316.

Score Interpretation Ranges

Low Risk0 – 39 pts

<40th percentile

Low-Intermediate Risk40 – 75 pts

40th-75th percentile

High-Intermediate Risk76 – 94 pts

76th-94th percentile

High Risk95 – 100 pts

≥95th percentile

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.